With the emergence and integration of advanced drug, device, and biotech research methodologies, start-ups to multi-national biomedical companies have accelerated their pace of in-human trials. They now rely upon CROs and SMOs as strategic, value-added outsource entities for study operations.
NICR is highly cognizant of and responsive to the unique needs, time lines, and financial accounting of CROs and SMOs. NICR is flexible and able to provide limited, or all available, services according to your project requirements/parameters. NICR maintains a high level of discretion preserving CRO and SMO confidentiality.